These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10401251)

  • 21. Probiotics in allergy management.
    Vanderhoof JA
    J Pediatr Gastroenterol Nutr; 2008 Nov; 47 Suppl 2():S38-40. PubMed ID: 18931598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of bifidumbacterin in young children with acute intestinal diseases].
    Protoklitova NS; Sterligova ND; Naumova MA; Romanov MV
    Vopr Okhr Materin Det; 1977; 22(2):54-8. PubMed ID: 841947
    [No Abstract]   [Full Text] [Related]  

  • 23. [Probiotics: history, definition, requirements and possible therapeutic applications].
    Montalto M; Arancio F; Izzi D; Cuoco L; Curigliano V; Manna R; Gasbarrini G
    Ann Ital Med Int; 2002; 17(3):157-65. PubMed ID: 12402663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose probiotics for the treatment of active pouchitis.
    Gionchetti P; Rizzello F; Morselli C; Poggioli G; Tambasco R; Calabrese C; Brigidi P; Vitali B; Straforini G; Campieri M
    Dis Colon Rectum; 2007 Dec; 50(12):2075-82; discussion 2082-4. PubMed ID: 17934776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of small intestine bacterial overgrowth.
    Di Stefano M; Miceli E; Missanelli A; Corazza GR
    Eur Rev Med Pharmacol Sci; 2005; 9(4):217-22. PubMed ID: 16128041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lamivudine treatment for acute severe hepatitis B: a pilot study.
    Schmilovitz-Weiss H; Ben-Ari Z; Sikuler E; Zuckerman E; Sbeit W; Ackerman Z; Safadi R; Lurie Y; Rosner G; Tur-Kaspa R; Reshef R
    Liver Int; 2004 Dec; 24(6):547-51. PubMed ID: 15566503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intestinal colonisation, microbiota and future probiotics?
    Salminen S; Benno Y; de Vos W
    Asia Pac J Clin Nutr; 2006; 15(4):558-62. PubMed ID: 17077076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A report of recombinant interferon-alpha therapy in 19 patients with acute hepatitis B].
    Li X; Cui Z; Zhang F
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Sep; 13(3):295-7. PubMed ID: 12569769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteria: a new player in gastrointestinal motility disorders--infections, bacterial overgrowth, and probiotics.
    Quigley EM
    Gastroenterol Clin North Am; 2007 Sep; 36(3):735-48, xi. PubMed ID: 17950446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults.
    Larsen CN; Nielsen S; Kaestel P; Brockmann E; Bennedsen M; Christensen HR; Eskesen DC; Jacobsen BL; Michaelsen KF
    Eur J Clin Nutr; 2006 Nov; 60(11):1284-93. PubMed ID: 16721394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
    Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The efficacy of the eubiotic bifacide when used in the combined antibacterial therapy of newborn infants with infectious-inflammatory diseases].
    Kushnareva MV; Dement'eva GM; Chernonog IN; Frolova MI; Feklisova LV; Rebrova TN
    Antibiot Khimioter; 1996; 41(11):28-32. PubMed ID: 9214283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
    Hütt P; Shchepetova J; Lõivukene K; Kullisaar T; Mikelsaar M
    J Appl Microbiol; 2006 Jun; 100(6):1324-32. PubMed ID: 16696680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of probiotic bifiform on efficacy of Helicobacter pylori infection treatment].
    Iakovenko EP; Grigor'ev PIa; Iakovenko AV; Agafonova NA; Prianishnikova AS; Sheregova EN; Vasil'ev IV; Komleva IuV; Oprishchenko IV; Anashkin VA
    Ter Arkh; 2006; 78(2):21-6. PubMed ID: 16613091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correction of intestinal dysbacteriosis with biological preparations in acute leukemia].
    Tolkacheva TV; Abakumov EM; Martynova VA; Golosova TV
    Probl Gematol Pereliv Krovi; 1981 Jul; 26(7):29-33. PubMed ID: 7279892
    [No Abstract]   [Full Text] [Related]  

  • 36. Prospects for the use of probiotic bacteria in the treatment of gastrointestinal diseases in dogs.
    Chrzastowska M; Kander M; Depta A
    Pol J Vet Sci; 2009; 12(2):279-84. PubMed ID: 19645362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Impaired interferon status in children with acute respiratory infection and its correction with bifidumbacterin-forte].
    Lykova EA; Vorob'ev AA; Bokovoĭ AG; Murashova AO
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (2):65-7. PubMed ID: 11548264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chemotherapy and the state of immunity in bacterial intestinal infections].
    Bunin KV
    Sov Med; 1979 May; (5):13-8. PubMed ID: 451717
    [No Abstract]   [Full Text] [Related]  

  • 39. [The use of sporulating bacteria in treating patients with dysbacteriosis].
    Voĭchishina LG; Chaplinskiĭ VIa; V'iunitskaia VA
    Vrach Delo; 1991 Dec; (12):73-5. PubMed ID: 1792782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Optimization of treatment of children with acute intestinal infections by application of Russian biological microbial preparations].
    Feklisova LV
    Vestn Ross Akad Med Nauk; 2005; (12):17-24. PubMed ID: 16404978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.